Načítá se...
Lamivudine resistance in children with chronic hepatitis B
Currently, although lamivudine (LAM) has a low genetic barrier, only interferon-alpha and LAM are available as a first-line treatment in children with chronic hepatitis B (CHB). LAM is a potent inhibitor of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) polymerase replication by termination of th...
Uloženo v:
| Vydáno v: | World J Hepatol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411531/ https://ncbi.nlm.nih.gov/pubmed/25937866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i6.896 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|